PRME
Prime Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
−0.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 67.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.86x
- Price / sales
- 164.77x
- Price / cash flow
- -4.30x
Enterprise value
- Enterprise value
- $688.5M
- EV / sales
- 169.04x
- EV / EBITDA
- -3.81x
- EV / EBIT
- -3.50x
- Market cap
- $671.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026